All News

ESMO21: Mirati's adagrasib continues to impress in colorectal cancer

Ref: ESMO

Tags: Top Story Mirati Therapeutics Colorectal Cancer Clinical Research (R&D) Medical Affairs ESMO Congress adagrasib Erbitux

Drugmaker Ipsen Picks Lazard for Review of Consumer Health Unit

Ref: Bloomberg

Tags: NewsPoints Ipsen Corporate Affairs Mergers & Acquisitions

Exelixis Announces U.S. FDA Approval of CABOMETYX (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Ref: Business Wire

Tags: Press Release Exelixis Thyroid Disorders FDA Marketing & Sales Regulatory Affairs Cabometyx

Drug developer AEON Biopharma files for a $75 million IPO

Ref: Renaissance Capital

Tags: NewsPoints AEON Biopharma Migraine Corporate Affairs ABP-450

Incyte Announces Health Canada Conditional Approval of Pemazyre (pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma

Ref: CNW

Tags: Press Release Incyte Innovent Biologics Health Canada Marketing & Sales Regulatory Affairs Pemazyre

New findings on B cells may improve vaccine design

Ref: Karolinska Institutet

Tags: Press Release Karolinska Institutet Immunisation Clinical Research (R&D)

Study rules out an antioxidant treatment for slowing the progression of Parkinson’s disease: Researchers find no therapeutic benefit to raising the level of urate in the brain

Ref: Massachusetts General Hospital

Tags: Press Release Parkinson's Clinical Research (R&D) Medical Affairs

SEC Charges Former Pharmaceutical Global IT Manager in $8 Million Insider Trading Scheme

Ref: SEC

Tags: Press Release Mylan Viatris United States Corporate Affairs

Swissmedic is reviewing the authorisation extension for a third dose of the COVID-19 vaccines from Pfizer

Ref: Swissmedic

Tags: Press Release BioNTech J&J Moderna Pfizer COVID-19 Immunisation Swissmedic Marketing & Sales Regulatory Affairs Spikevax Comirnaty

WHO calls on world leaders at the UN General Assembly to focus on vaccine equity, pandemic preparedness, and getting the SDGs back on track

Ref: WHO

Tags: Press Release Immunisation COVID-19 WHO Medical Affairs